Register to chat with like-minded investors on our interactive forums.
The current LDX market cap is 14.92M. The company's latest EPS is USD -0.0179 and P/E is -1.68.
| Year End 30 June 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| AUD (AUD) | AUD (AUD) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 8.4M | 25.06M | 11.63M | 10.54M | 11.13M |
| Operating Income | -12.81M | -14.57M | -39.1M | -9.06M | -7.03M |
| Net Income | -13.45M | -20.13M | -45.72M | -8.97M | -8.59M |
| Year End 30 June 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| AUD (AUD) | AUD (AUD) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 43.87M | 130.55M | 36.94M | 25.42M | 26.84M |
| Total Liabilities | 11.77M | 52.82M | 19.06M | 15.92M | 19.73M |
| Total Equity | 32.1M | 77.73M | 17.89M | 9.5M | 7.11M |
| Year End 30 June 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| AUD (AUD) | AUD (AUD) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -5.45M | -8.52M | -18.04M | -9.64M | 946k |
| Investing | -9.45M | -13.75M | -4.36M | 4.31M | -98k |
| Financing | 11.76M | 80.91M | -10.92M | 652k | 2.63M |
| Market Cap | 14.92M |
| Price to Earnings Ratio | -1.68 |
| Price to Sales Ratio | 1.3 |
| Price to Cash Ratio | 2.22 |
| Price to Book Ratio | 2.03 |
| Dividend Yield | - |
| Shares Outstanding | 481.31M |
| Average Volume (1 week) | 2.63M |
| Average Volume (1 Month) | 1.91M |
| 52 Week Change | -52.31% |
| 52 Week High | 0.1075 |
| 52 Week Low | 0.028 |
| Spread (Intraday) | 0 (6.25%) |
| Company Name | Lumos Diagnostics Holdings Ltd |
| Address |
level 4 melbourne, victoria 3205 |
| Website | https://lumosdiagnostics.com |
| Industry | in vitro,in vivo diagnostics (2835) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
